论文部分内容阅读
目的:分析研究中西医结合治疗肺癌临床疗效。方法:选取72例肺癌患者,随机分为观察组与对照组各36例。对照组患者采用西医方法给予治疗;观察组患者在对照组治疗基础上加用中医药治疗,将两组患者近期与远期治疗效果进行对比。结果:观察组患者近期治疗总有效率(77.8%)明显高于对照组,差异具有统计学意义(P<0.05);观察组患者1~5年内生存率明显高于对照组,差异具有统计学意义(P<0.05)。结论:采用中西医结合治疗肺癌患者,能够有效控制肿瘤发展,延长患者生存时间,降低化疗产生的毒副作用,对提高患者生存质量有着重要意义,值得临床推广应用。
Objective: To analyze the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of lung cancer. Methods: 72 patients with lung cancer were randomly divided into observation group and control group, 36 cases each. Patients in the control group were treated by western medicine. Patients in the observation group were treated with traditional Chinese medicine on the basis of the control group, and the short-term and long-term effects of the two groups were compared. Results: The total effective rate (77.8%) in the observation group was significantly higher than that in the control group (P <0.05). The survival rate in the observation group was significantly higher than that in the control group within 1 to 5 years, and the difference was statistically significant Significance (P <0.05). Conclusion: The treatment of lung cancer patients with integrated traditional Chinese and western medicine can effectively control the tumor development, prolong the survival time of patients and reduce the side effects caused by chemotherapy, which is of great significance to improve the quality of life of patients and is worthy of clinical application.